Shop By Category

Latest Collections

Biosimilar reference antibodies

Anti-LY6G6D(Genentech biosimilar) mAb

SKU:  BME100303     Target:  LY6G6D

Application:  ELISA,Flow Cyt

Price: 50 μg ¥800.00 ; 100 μg ¥1500.00

Biosimilar reference antibodies

Anti-TGFBR2(LY3022859 biosimilar) mAb

SKU:  BME100302     Target:  TGFBR2

Application:  ELISA,Flow Cyt

Price: 50 μg ¥800.00 ; 100 μg ¥1500.00

Biosimilar reference antibodies

Anti-4-1BB Ligand(SC113.153 biosimilar) mAb

SKU:  BME100300     Target:  4-1BB Ligand

Application:  ELISA,Flow Cyt

Price: 50 μg ¥800.00 ; 100 μg ¥1500.00

Biosimilar reference antibodies

Anti-FAP(sibrotuzumab biosimilar) mAb

SKU:  BME100298     Target:  FAP

Application:  Flow Cyt

Price: 50 μg ¥800.00 ; 100 μg ¥1500.00

Biosimilar reference antibodies

Anti-IL11(BI-765423 biosimilar) mAb

SKU:  BME100295     Target:  IL11

Application:  ELISA

Price: 50 μg ¥800.00 ; 100 μg ¥1500.00

Biosimilar reference antibodies

Anti-CGRP(Eptinezumab biosimilar) mAb

SKU:  BME100177     Target:  CGRP

Application:  ELISA

Price: 50 μg ¥800.00 ; 100 μg ¥1500.00

SKU:  DME101359     Target:  HEL Rabbit IgG1

Application:  N/A

Price: 10μg ¥690.00 ; 50μg ¥2280.00 ; 100 μg ¥4080.00 ; 500 μg ¥13280.00

SKU:  FLP100616B     Target:  CACNG1     Tag:  C-Flag&Avi Tag

Price:10 μg ¥6930.00 ; 50 μg ¥33000.00 ; 100 μg ¥60500.00

How it Works

Apply to be a Vendor

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

Upload your products

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

Sell and make money

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

Latest Reviews

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat….

Name / Lastname

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat….

Name / Lastname

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat….

Name / Lastname

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat….

Name / Lastname

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat….

Name / Lastname

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat….

Name / Lastname

From The Blog

G蛋白偶联受体84/GPR84:连接代谢与免疫的新兴靶点

近年来,代谢-免疫交叉成为药物研发的重要方向,其中G蛋白偶联受体8…

TfR1/TFRC/CD71:从铁代谢到脑递送入口

2025年,罗氏更新trontinemab临床数据后,TfR1介导…

从血脑屏障穿梭机制看治疗性靶点:谁更有机会把药真正送进脑内?

血脑屏障(BBB)正成为神经系统药物递送的关键入口。随着 Tron…

从BD到临床:2026Q1自免赛道的真正主线浮出水面

2026年第一季度,自身免疫领域的进展不再是“零散创新”,而是围绕…

2026年3月交易速递:从ADHD到T细胞衔接器,总金额超400亿!

全球BD交易在3月集中爆发,呈现出明显的结构性特征:一方面,大额并…

【AACR 2026】GPCR靶点:从CXCR4到GPRC5D,哪些方向正在走热?

在2026 AACR会议上,GPCR相关项目已经明显从传统小分子受…

【AACR 2026】抗体偶联药物(ADC)有哪些热门靶点?

从摘要频次看,AACR 2026 ADC热门靶点大致如下:HER2…

SLC7A11/xCT:从铁死亡到免疫疗法,肿瘤治疗的多维新战场

在肿瘤治疗中,“铁死亡”(Ferroptosis)成为突破耐药肿瘤…